Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New antiplatelet and antithrombotic agent characterized by Taisho

March 31, 1998

Toyama researchers characterize antiplatelet/antithrombotic effects of T-250

March 31, 1998

Platelet antiaggregatory effects of liposome-encapsulated streptokinase

March 30, 1998

Z-335 demonstrates beneficial effects in models of peripheral circulatory insufficiency

March 30, 1998

DuPont Merck obtains U.S. rights for anticoagulant

March 27, 1998

Selective factor Xa inhibitors in development at Banyu

March 25, 1998

Antiplatelet agents disclosed by Nippon Steel

March 25, 1998

PPL reports expression of FIX at high concentrations in milk of transgenic sheep

March 25, 1998

Merck & Co. research leads to new fibrinogen receptor antagonist prodrugs

March 24, 1998

Lilly describes PAI-1-inhibitory benzothiophenes with cardioprotective effects

March 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...